Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine

Vaccine

Volumn 33, Issue 46, 2015, Pages 6173-6177

  Magnus, Per ^a   Gunnes, Nina ^a   Tveito, Kari ^b   Bakken, Inger Johanne ^a   Ghaderi, Sara ^a   Stoltenberg, Camilla ^a   Hornig, Mady ^c   Lipkin, W Ian ^c   Trogstad, Lill ^a   Håberg, Siri E ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Research Institute of the Norwegian Medical Association   (Norway)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Chronic fatigue syndrome myalgic encephalomyelitis (CFS ME); Cohort; Influenza vaccine; Pandemic influenza

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ARTICLE; CHRONIC FATIGUE SYNDROME; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HEALTH SERVICE; ICD-10; INCIDENCE; INFLUENZA A VIRUS (H1N1); INFLUENZA VACCINATION; MASS IMMUNIZATION; NORWAY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RISK FACTOR; ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMAN; INFANT; INFLUENZA; MALE; MIDDLE AGED; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; RISK ASSESSMENT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NORWAY; RISK ASSESSMENT; YOUNG ADULT;

EID: 84946606949     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.10.018     Document Type: Article

References (44)

1. Nohynek H., Jokinen J., Partinen M., Vaarala O., Kirjavainen T., Sundman J., et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012, 7:e33536.
2. Miller E., Andrews N., Stellitano L., Stowe J., Winstone A.M., Shneerson J., et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013, 346:f794.
3. Wijnans L., Lecomte C., de Vries C., Weibel D., Sammon C., Hviid A., et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013, 31:1246-1254.
4. Salmon D.A., Proschan M., Forshee R., Gargiullo P., Bleser W., Burwen D.R., et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013, 381:1461-1468.
5. Wise M.E., Viray M., Sejvar J.J., Lewis P., Baughman A.L., Connor W., et al. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol 2012, 175:1110-1119.
6. Vellozzi C., Iqbal S., Stewart B., Tokars J., DeStefano F. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Am J Public Health 2014, 104:696-701.
7. Israeli E., Agmon-Levin N., Blank M., Chapman J., Shoenfeld Y. Guillain-Barré syndrome - a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol 2012, 42:121-130.
8. Winer J.B. An update in Guillain-Barré syndrome. Autoimmune Dis 2014, 2014:793024.
9. De la Herrán-Arita A.K., García-García F. Narcolepsy as an immune-mediated disease. Sleep Disord 2014, 2014:792687.
10. Mahlios J., De la Herrán-Arita A.K., Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013, 23:767-773.
11. Committee on the Diagnostic Criteria for ME/CFS Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness 2015, Institute of Medicine, National Academy of Sciences, Washington, DC.
12. Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun 2010, 24:1209-1217.
13. Lorusso L., Mikhaylova S.V., Capelli E., Ferrari D., Ngonga G.K., Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009, 8:287-291.
14. Curriu M., Carrillo J., Massanella M., Rigau J., Alegre J., Puig J., et al. Screening NK-, B- and T-cell phenotype and function in patients suffering from chronic fatigue syndrome. J Transl Med 2013, 11:68.
15. Brenu E.W., Ashton K.J., van Driel M., Staines D.R., Peterson D., Atkinson G.M., et al. Cytotoxic lymphocyte microRNAs as prospective biomarkers for chronic fatigue syndrome/myalgic encephalomyelitis. J Affect Disord 2012, 141:261-269.
16. Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Hardcastle S.L., Keane J., et al. Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med 2012, 10:88.
17. Broderick G., Katz B.Z., Fernandes H., Fletcher M.A., Klimas N., Smith F.A., et al. Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med 2012, 10:191.
18. Briggs N.C., Levine P.H. A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. Clin Infect Dis 1994, 18(Suppl. 1):S32-S42.
19. Corridan J.P. 'Epidemic neuromyasthenia' in Southwest Ireland. Postgrad Med J 1978, 54:731-736.
20. Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S.D., et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006, 10.1136/bmj.38933.585764.AE.
21. Ramsay A.M. 'Epidemic neuromyasthenia' 1955-1978. Postgrad Med J 1978, 54:718-721.
22. Poskanzer D.C., Henderson D.A., Kunkle C., Kalter S.S., Clement W.B., Bond J.O. Epidemic neuromyasthenia; an outbreak in Punta Gorda, Florida. N Engl J Med 1957, 257:356-364.
23. Naess H., Nyland M., Hausken T., Follestad I., Nyland H.I. Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence. BMC Gastroenterol 2012, 12:13.
24. Katz B.Z., Jason L.A. Chronic fatigue syndrome following infections in adolescents. Curr Opin Pediatr 2013, 25:95-102.
25. Bradley A.S., Ford B., Bansal A.S. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol 2013, 172:73-80.
26. Morris G., Berk M., Galecki P., Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Mol Neurobiol 2013, 49(Sept):741-756.
27. Ortega-Hernandez O-D., Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence. Ann NY Acad Sci 2009, 1173:600-609.
28. Håberg S.E., Trogstad L., Gunnes N., Wilcox A.J., Gjessing H.K., Samuelsen S.O., et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013, 268:333-340.
29. Bakken I.J., Estenstad M.G., Gystad S.O., Nemeth J., Huse U.E. New Norwegian patient registry gives new research possibilities (in Norwegian). Norw J Epidemiol 2010, 20:119-124.
30. Trogstad L., Ung G., Hagerup-Jenssen M., Cappelen I., Haugen I., Feiring B. The Norwegian immunisation register-SYSVAK. Eurosurveillance 2012, 17(16). 〈http://www.eurosurveillance.org〉 (pii=20147).
31. Norwegian Institute of Public Health. Surveillance of communicable diseases and nosocomial infections in Norway 2006. Trends and main prevention strategies. Available at: http://www.fhi.no/dav/3d326fd31e.pdf.
32. Norwegian Institute of Public Health Report on the use of vaccination during the pandemic, version 2 September 2011, Norwegian Institute of Public Health, Available at: 〈http//www.fhi.no/dav/c0d224ad77.pdf〉 (in Norwegian).
33. Hayward A.C., Fragaszy E.B., Bermingham A., Wang E., Copas A., Edmunds J.W., et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir Med 2014, 2:445-454.
34. De Blasio B.F., Iversen B.G., Tomba G.S. Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway-and the influence of vaccination timing. PLoS ONE 2012, 7:e30018.
35. Bakken I.J., Tveito K., Gunnes N., Ghaderi S., Stoltenberg C., Trogstad L., et al. Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. BMC Med 2014, 12:167.
36. Wessely S., Chalder T., Hirsch S., Pawlikowska T., Wallace P., Wright D.J.M. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995, 345:1333-1338.
37. Cope H., David A., Pelosi A., Mann A. Predictors of chronic postviral fatigue. Lancet 1994, 344:864-868.
38. Petersen I., Thomas J.M., Hamilton W.T., White P.D. Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. Q J Med 2006, 99:49-55.
39. Imboden J.B., Canter A., Cluff L.E. Convalescence from influenza. Arch Int Med 1961, 108:115-121.
40. Vallings R. A case of chronic fatigue syndrome triggered by influenza H1N1 (swine influenza). J Clin Pathol 2010, 63:184-185.
41. Prinsen H., de Vries I.J., Torensma R., Pots J.M., Mulder S.F., van Herpen C.M.L., et al. Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome. BMC Immunol 2012, 13:71.
42. Sleigh K.M., Danforth D.G., Hall R.T., Fleming J.A., Stiver H.G. Double-blind, randomized study of the effects of influenza vaccination on the specific antibody response and clinical course of patients with chronic fatigue syndrome. Can J Infect Dis 2000, 11:267-273.
43. Brenu E.W., van Driel M., Staines D.R., Kreijkamp-Kaspers S., Hardcastle S.L., Marshall-Gradisnik S.M. The effects of influenza vaccination on immune function in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Int J Clin Med 2012, 3:544-551.
44. Magnus P., Brubakk O., Nyland H., Wold B.H., Gjessing H.K., Brandt I., et al. Vaccination as teenagers against meningococcal disease and the risk of the chronic fatigue syndrome. Vaccine 2009, 27:23-27.